A new trading day began on Monday, with Annovis Bio Inc (NYSE: ANVS) stock price up 6.62% from the previous day of trading, before settling in for the closing price of $9.21. ANVS’s price has ranged from $4.53 to $22.49 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 72.54%. With a float of $10.24 million, this company’s outstanding shares have now reached $10.52 million.
The extent of productivity of a business whose workforce counts for 6 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Annovis Bio Inc (ANVS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Annovis Bio Inc is 21.56%, while institutional ownership is 7.98%.
Annovis Bio Inc (ANVS) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.63 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.54% per share during the next fiscal year.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Here are Annovis Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.51, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.81 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
The latest stats from [Annovis Bio Inc, ANVS] show that its last 5-days average volume of 0.75 million was inferior to 0.81 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.59%. Additionally, its Average True Range was 0.73.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 39.63%, which indicates a significant decrease from 87.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.94% in the past 14 days, which was lower than the 144.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.45, while its 200-day Moving Average is $9.24. Now, the first resistance to watch is $10.35. This is followed by the second major resistance level at $10.89. The third major resistance level sits at $11.56. If the price goes on to break the first support level at $9.14, it is likely to go to the next support level at $8.47. The third support level lies at $7.93 if the price breaches the second support level.
Annovis Bio Inc (NYSE: ANVS) Key Stats
With a market capitalization of 128.15 million, the company has a total of 11,171K Shares Outstanding. Currently, annual sales are 0 K while annual income is -56,200 K. The company’s previous quarter sales were 0 K while its latest quarter income was -5,020 K.
